These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7523865)

  • 1. SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice.
    Bright RK; Shearer MH; Kennedy RC
    Mol Immunol; 1994 Oct; 31(14):1077-87. PubMed ID: 7523865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.
    Bright RK; Shearer MH; Kennedy RC
    Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
    Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
    J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expression.
    Bright RK; Shearer MH; Kennedy RC
    Cancer Immunol Immunother; 1993 Jul; 37(1):31-9. PubMed ID: 7685654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
    Bright RK; Shearer MH; Pass HI; Kennedy RC
    Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of in vitro- and in vivo-generated cytotoxic T cells with SV40 T antigen: analysis with synthetic peptides.
    Alsheikhly AR
    Scand J Immunol; 1994 May; 39(5):467-79. PubMed ID: 8191222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
    Mylin LM; Deckhut AM; Bonneau RH; Kierstead TD; Tevethia MJ; Simmons DT; Tevethi SS
    Virology; 1995 Apr; 208(1):159-72. PubMed ID: 11831696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice.
    Shearer MH; Lanford RL; Kennedy RC
    J Immunol; 1990 Aug; 145(3):932-9. PubMed ID: 1695650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.
    Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC
    Cancer Immunol Immunother; 1999 Feb; 47(6):343-51. PubMed ID: 10203065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells.
    Santos M; Butel JS
    J Virol; 1984 Aug; 51(2):376-83. PubMed ID: 6205166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen.
    Soule HR; Lanford RE; Butel JS
    J Virol; 1980 Feb; 33(2):887-901. PubMed ID: 6157837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocytes in SV40 infections.
    Schell TD; Tevethia SS
    Methods Mol Biol; 2001; 165():243-56. PubMed ID: 11217391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.